Item 2.02. Results of Operations and Financial Condition.

On January 12, 2021, Luminex Corporation ("the Company") issued a press release announcing preliminary revenue for the fourth quarter and full year 2020. A copy of the press release is furnished herewith as Exhibit 99.1.

The information in this Form 8-K and the Exhibits attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 7.01. Regulation FD Disclosure.

On January 13, 2021, the Company is giving a presentation ("Investor Presentation") to investors discussing, among other topics, an overview of the Company's business and growth strategy. The presentation will be at the 39th Annual J.P. Morgan Healthcare Conference, to be held virtually, and will begin at 3:30 p.m. Central Time (4:30 p.m. Eastern Time). A copy of the Investor Presentation, which is available at www.luminexcorp.com, is being furnished as Exhibit 99.2 to this Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.
Exhibit No.                Description
  99.1                       Press Release issued by Luminex Corporation dated January 13, 2021.
  99.2                       Investor Presentation

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses